1. Lesley Lesley United Kingdom says:

    As with most pharmaceutical drugs, this has a long list of potential side effects.  GcMAF, on the other hand, is a naturally occuring protein in a healthy immune system.  Dr Bradstreet discovered that autistic children have a higher than normal level of nagalase, and this disrupts the body's ability to make GcMAF.  By reintroducing this protein, he found that 85% responded positively and some even went on to lose the label of autism as they no longer displayed autistic traits.  See his speech on it (the paper to which he refers was peer-reviewed and published this week) http://www.youtube.com/watch?v=FZ5wog0oig0 .  I fail to understand why FirstImmune GcMAF does not get more publicity.  I've met parents whose children are now verbal after starting the therapy, yet no media writes up about this.  Seeing the joy on the parents faces, this new discovery should be shouted from the rooftops.  Its making me feel that the 'conspiracy theorists' have a point, that media is owned and managed by big money including big pharma.

    • Chanda Esparza Chanda Esparza United States says:

      This is the first time I've ever heard any mention of GcMAF therapy. I have an autistic son and I'm willing to try anything to help him be normal. Now I need to learn more about this GcMAF therapy.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.